Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
about
New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genesExamining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries.Ovarian Cancer Prevention in High-risk Women.Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
P2860
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@ast
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@en
type
label
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@ast
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@en
prefLabel
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@ast
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@en
P2093
P1476
Germline BRCA1/2 mutation test ...... n cancer: A systematic review.
@en
P2093
C Marleen Kets
Geertruida H de Bock
Joanne A de Hullu
Marian J E Mourits
Marieke Arts-de Jong
P304
P356
10.1016/J.EJCA.2016.03.009
P577
2016-05-17T00:00:00Z